Cargando…
Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA
Upon the discovery of RNA interference (RNAi), canonical small interfering RNA (siRNA) has been recognized to trigger sequence-specific gene silencing. Despite the benefits of siRNAs as potential new drugs, there are obstacles still to be overcome, including off-target effects and immune stimulation...
Autores principales: | Raja, Maria Abdul Ghafoor, Katas, Haliza, Amjad, Muhammad Wahab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032099/ https://www.ncbi.nlm.nih.gov/pubmed/32104477 http://dx.doi.org/10.1016/j.ajps.2018.12.005 |
Ejemplares similares
-
Development of Chitosan Nanoparticles as a Stable Drug Delivery System for Protein/siRNA
por: Katas, Haliza, et al.
Publicado: (2013) -
Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers
por: Abdul Ghafoor Raja, Maria, et al.
Publicado: (2015) -
Single-pot enzymatic synthesis of Dicer-substrate siRNAs
por: Guiley, Keelan Z., et al.
Publicado: (2012) -
Evaluation of Canonical siRNA and Dicer Substrate RNA for Inhibition of Hepatitis C Virus Genome Replication – A Comparative Study
por: Carneiro, Bruno, et al.
Publicado: (2015) -
Rational design for controlled release of Dicer-substrate siRNA harbored in phi29 pRNA-based nanoparticles
por: Binzel, Daniel W., et al.
Publicado: (2021)